OREX - Orexigen Therapeutics, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts0011
Avg. Estimate00-7.13-3.54
Low Estimate00-7.13-3.54
High Estimate00-7.13-3.54
Year Ago EPS-2.06-3.2-9.75-7.13
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts1111
Avg. Estimate25M27.5M84.7M156.5M
Low Estimate25M27.5M84.7M156.5M
High Estimate25M27.5M84.7M156.5M
Year Ago Sales13.81M19.14M33.71M84.7M
Sales Growth (year/est)81.10%43.60%151.30%84.80%
Earnings History9/29/201612/30/20166/29/20179/29/2017
EPS Est.-2.24-1.18-2.4-2.13
EPS Actual-2.06-3.2-2-1.35
Difference0.18-2.020.40.78
Surprise %8.00%-171.20%16.70%36.60%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate00-7.13-3.54
7 Days Ago-2.06-2.17-7.13-3.54
30 Days Ago-2.06-2.17-8.61-5.15
60 Days Ago-2.06-2.17-8.61-5.15
90 Days Ago-2.06-2.17-8.61-5.15
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesOREXIndustrySectorS&P 500
Current Qtr.N/AN/AN/A0.42
Next Qtr.N/AN/AN/A0.39
Current Year26.90%N/AN/A0.20
Next Year50.40%N/AN/A0.10
Next 5 Years (per annum)-78.50%N/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A